Lobular Carcinoma In Situ (LCIS)

 

Epidemiology:

 

Common sites:

 

Gross features:

 

Histologic features:

 

Immunophenotype:

Marker:

Sensitivity:

Specificity:

ER, PR 

Almost always

(up to 90%)

(pleomorphic LCIS is more likely to be neg)

 

e-cadherin (neg)

80-90% of LCIS and invasive lobular carcinoma

 

HER2 (neg)

Typically

(pleomorphic may be +)

 

P53 (neg)

Typically

(pleomorphic may be positive)

 

Ki-67

Higher in pleomorphic LCIS

 

 

Molecular features:

 

Other features:

 

References: